article thumbnail

Lilly and EVA Pharma to aid affordable insulin access in Africa

European Pharmaceutical Review

Lilly’s 30×30 initiative aims to improve access to quality healthcare for 30 million people living in limited-resource settings, annually, by 2030. Communication with WHO encourage implementation of and accountability for the commitments and contributions toward improving access to insulin.

article thumbnail

Philips on designing innovation and cultivating partnerships – part two

pharmaphorum

It’s a package, and sometimes we deploy one or two modules, sometimes multiple modules in a project. “That is something very unique because there are lots of patient apps out there, but they do not communicate with the doctor. The only aspects Philips does not provide are health workers and the supply chain for drugs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Disrupted medical conferences: 2022 and beyond

pharmaphorum

Moreover, no attendee data was available for physical symposia, whereas all virtual symposia packages provided full attendee metrics analyses. Since then, many societies have indeed made discernible progress towards digital transformation of their events and communications practices. Postscript. www.conferencecompass.com.

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). Nature Communications 12, no. Biotechnology Progress 36, no. 3 (2020):e2970.

article thumbnail

A New Regulatory Approach to Drive Sustainable Medicines

ISPE

As such there’s a growing question of how the industry will improve the sustainability profile of its existing medicines and ensure that sustainability is designed into new medicines, such as products, with a reduced environmental risk, greener manufacturing technologies, and recyclable delivery systems and packaging. 9 December 2021.

article thumbnail

Challenges for Net Zero Carbon Pharmaceutical Manufacturing

ISPE

C global warming scenario by 2030, which is widely acknowledged to be necessary to avoid the worst impacts of climate change. solvent selection, inhaler propellant replacement, and packaging design) to employee travel and commute policy (e.g., recycled content in packaging, reduction of packaging weights).

article thumbnail

Sustainability: Corporate Ambition, Governance, & Accelerated Delivery

ISPE

Transforming Our World: The 2030 Agenda for Sustainable Development.” a time horizon of 2030 is much more engaging than 2050). Firms co-located in a shared building or on a shared campus might also work together to reduce the environmental impact of communal energy streams. 1 United Nations. October 2015. link] 2 United Nations.